Health care and societal costs of the management of children and adolescents with attention-deficit/hyperactivity disorder in Spain : a descriptive analysis

Autor: Quintero, Javier, Ramos-Quiroga, Josep Antoni, Sebastián, Javier San, Montañés, Francisco, Fernández-Jaén, Alberto, Martínez-Raga, José, García Giral, Marta, Graell, Montserrat, Mardomingo, María J., Soutullo, César, Eiris, Jesús, Téllez, Montserrat, Pamias, Montserrat, Correas, Javier, Sabaté, Juncal, García-Orti, Laura, Alda, José A., Universitat Autònoma de Barcelona. Departament de Psiquiatria i de Medicina Legal
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Zdroj: BMC Psychiatry
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Bmc Psychiatry
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Quintero, Javier Ramos Quiroga, J.Antoni San Sebastián, Javier Montañés, Francisco Fernández Jaén, Alberto Martínez Raga, José Garcia Giral, Marta Graell, Montserrat Mardomingo, Maria J. Soutullo, César Eiris, Jesús Téllez, Montserrat Pamias, Montserrat Correas, Javier Sabaté, Juncal García Orti, Laura Alda, Jose A. 2018 Health care and societal costs of the management of children and adolescents with attention-deficit/hyperactivity disorder in Spain: a descriptive analysis. Bmc Psychiatry 18 1 40
RODERIC: Repositorio Institucional de la Universitat de Valéncia
Universitat de València
BMC Psychiatry, Vol 18, Iss 1, Pp 1-10 (2018)
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid
RODERIC. Repositorio Institucional de la Universitat de Valéncia
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu
ISSN: 1471-244X
Popis: Background Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental condition in childhood (5.3% to 7.1% worldwide prevalence), with substantial overall financial burden to children/adolescents, their families, and society. The aims of this study were to describe the clinical characteristics of children and adolescents with ADHD in Spain, estimate the associated direct/indirect costs of the disorder, and assess whether the characteristics and financial costs differed between children/adolescents adequately responding to currently available pharmacotherapies compared with children/adolescents for whom pharmacotherapies failed. Methods This was a multicenter, cross-sectional, descriptive analysis conducted in 15 health units representative of the overall Spanish population. Data on demographic characteristics, socio-occupational status, social relationships, clinical variables of the disease, and pharmacological and non-pharmacological treatments received were collected in 321 children and adolescents with ADHD. Direct and indirect costs were estimated over one year from both a health care system and a societal perspective. Results The estimated average cost of ADHD per year per child/adolescent was €5733 in 2012 prices; direct costs accounted for 60.2% of the total costs (€3450). Support from a psychologist/educational psychologist represented 45.2% of direct costs and 27.2% of total costs. Pharmacotherapy accounted for 25.8% of direct costs and 15.5% of total costs. Among indirect costs (€2283), 65.2% was due to caregiver expenses. The total annual costs were significantly higher for children/adolescents who responded poorly to pharmacological treatment (€7654 versus €5517; P = 0.024), the difference being mainly due to significantly higher direct costs, particularly with larger expenses for non-pharmacological treatment (P = 0.012). Conclusions ADHD has a significant personal, familial, and financial impact on the Spanish health system and society. Successful pharmacological intervention was associated with lower overall expenses in the management of the disorder. Electronic supplementary material The online version of this article (10.1186/s12888-017-1581-y) contains supplementary material, which is available to authorized users.
Databáze: OpenAIRE